96109 ⎘
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom; Six-membered rings Pyridine rings
Inhibitors of p38
#302Amorphous forms of risedronate monosodium
#303Process for the preparation of alkyl- and aryl-diphosphonic acids and salts thereof
#304Novel chelated bisphosphonates for use as pharmaceutical agents
#305Antiresorptive mutual salt of raloxifene and bisphosphonic acid
#306Metal complexes with bipodal ligands
#307Method for asymmetric synthesis
#308Chiral ligands and their transition metal complexes
#309Process for the preparation of bisphosphonic acid
#310Pyridine compounds as inhibitors of dipeptidyl peptidase IV
#311Substituted picolinamides as MAO-B inhibitors useful for treating obesity
#312Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
#313Process for preparation of bisphosphonic acid compounds
#314Light-emitting device containing bis-phosphineoxide compound
#315Process for the preparation of biphosphonic derivatives
#316Exo- and diastereo- selective syntheses of himbacine analogs
#317Novel heteroaryl phosphonates as cardioprotective agents
#318Heterocyclic carboxamides and their use as fungicides
#3191,1-and 1,2-Bisphosphonates as apoliprotein e modulators
#320Phosphonylated fluorescent dyes and conjugates
#321Catalysts containing N-pyrrolyl substituted nitrogen donors
#322Diarylurea derivatives and their use as chloride channel blockers
#323Crystalline form of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid
#324Substituted pyridyl amine catalysts and processes for polymerizing crystalline polymers
#325Method for making nitrile compounds from ethylenically unsaturated compounds
#326Novel process for making bisphosphonic acids using diluents other than halogenated hydrocarbons
#327Non nucleoside reverse transcriptase inhibitors
#328Hydroxyphosphonates and phosphonophosphates as apolipoprotein e modulators
#329Industrial process for the synthesis of 2-substituted 1-(hydroxy-ethylidene)-1,1-bisphosfi- conic acids of high purity and the salts thereof
#330Method and compositions for identifying anti-hiv therapeutic compounds
#331Novel inhibitors of beta-lactamase
#332Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
#333Carboxamide derivatives and their use as factor Xa inhibitors
#334Pyridyl inhibitors of hedgehog signalling
#335Aromatic compounds containing nitrogen and p- functionalized amines, the production thereof and their use in catalytic reactions
#336Making nitrile compounds from ethylenically unsaturated compounds
#337Phosphorus-containing thyromimetics
#338Noncardiotoxic pharmaceutical compounds
#339Preparation of biphosphonic acids and salts thereof
#340Compounds, compositions and methods for treating or preventing viral infections and associated diseases
#341Pyrimidyl phosphonate antiviral compounds and methods of use
#342Sulfonylethyl phosphorodiamidates
#343Methods for generating high titer helper-free preparations of released recombinant AAV vectors
#344Kinase inhibitory phosphonate analogs
#345Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
#346Phosphate/sulfate ester compounds and pharmaceutical composition for inhibiting protein interacting NIMA (PIN1)
#347Catalysts for olefin polymerization
#348Method and compositions for identifying anti-HIV therapeutic compounds
#349Amino phosphonate and amino bis-phosphonate derivatives
#350Mitochondrially targeted antioxidants
#351Amorphous 3-pyridil-1-hydroxyethyliden-1,1-biphosphonic acid monosodium salt and process for the preparation thereof
#352Anti-infective phosphonate analogs
#353Antiviral phosphonate analogs
#354Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
#355Functional biopolymer modification reagents and uses thereof
#356Non nucleoside reverse transcriptase inhibitors
#357Alpha-substituted beta-aminoethyl phosphonate derivatives
#358Chelating agents and highly luminescent and stable chelates and their use
#359HIV protease inhibiting compounds
#360Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels
#361Alpha-substituted arylalkyl phosphonate derivatives
#362Alpha-substituted heteroarylalkyl phosphonate derivatives
#363Ligands for use in catalytic processes
#364Phosphinic acids
#365Novel perines
#366Aminodiphosphonate apolipoprotein E modulators
#367Chain-breaking antioxidants
#368Catalysts containing N-pyrrolyl substituted nitrogen donors
#369Inhibitors of β-lactamase
#370Process for preparing haptens for immunoassay of phosphorothioate pesticides
#371Process for controlling crystal structure of risedronate
#372Bisphosphonate conjugates and methods of making and using the same
#373Chelants and macrocyclic metal complex radiopharmaceuticals thereof
#374Potassium channel modulators
#375Chelants and macrocyclic metal complex radiopharmaceuticals thereof
#376Multimer forms of acylphosphines and their derivatives